搜索结果101-110 的 825 / anti-TNF drugs

  1. 神经科- 临床试验- 妙佑医疗国际

    ... therapy and allow for collaborative research. The PPCR will collect ... drugs in the iPSC-derived muscle cells. A Study to Clarify the Relationship ...

  2. 神经科- 临床试验- 妙佑医疗国际

    Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma ... drugs in the iPSC-derived muscle cells ...

  3. 神经科- 临床试验- 妙佑医疗国际

    Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma ... drugs in the iPSC-derived muscle cells ...

  4. 神经科- 临床试验- 妙佑医疗国际

    Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma ... drugs in the iPSC-derived muscle cells ...

  5. 神经科- 临床试验- 妙佑医疗国际

    ... therapy and allow for collaborative research. The PPCR will collect ... drugs in the iPSC-derived muscle cells. Cerebral Spinal Fluid Evaluation in ...

  6. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  7. 神经科- 临床试验- 妙佑医疗国际

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

  8. 住院内科- 临床试验- 妙佑医疗国际

    ... therapy is in achieving euvolemia and the impact of their quantitated volume status at the time of hospital discharge on heart failure related morality and ...

  9. 神经科- 临床试验- 妙佑医疗国际

    Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

  10. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...